Ken Griffin Avantor, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$21.37 - $26.07 $2.4 Million - $2.93 Million	-112,300 Reduced 53.68%	96,900 $2.48 Million
Q4 2023 Feb 14, 2024	BUY	$17.15 - $23.08 $1.58 Million - $2.12 Million	91,900 Added 78.35%	209,200 $4.78 Million
Q3 2023 Nov 14, 2023	SELL	$20.23 - $23.33 $3.6 Million - $4.15 Million	-178,000 Reduced 60.28%	117,300 $2.47 Million
Q2 2023 Aug 14, 2023	SELL	$18.72 - $21.54 $849,888 - $977,916	-45,400 Reduced 13.33%	295,300 $6.07 Million
Q1 2023 May 15, 2023	BUY	$20.07 - $25.1 $5.32 Million - $6.66 Million	265,300 Added 351.86%	340,700 $7.2 Million

Q4 2022 Feb 14, 2023	SELL	$19.22 - $22.8 $10.9 Million - $12.9 Million	-566,900 Reduced 88.26%	75,400 $1.59 Million
Q3 2022 Nov 14, 2022	BUY	$19.6 - $32.33 $10.4 Million - $17.1 Million	530,200 Added 472.97%	642,300 $12.6 Million

523

642M

1.65M

9.65M

Ticker AVTR
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 674,035,008
Market Cap $14.3B
Description
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.